&Partners’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.28M Sell
5,695
-83
-1% -$29.4K 0.01% 951
2026
Q1
$1.86M Sell
5,778
-29
-0.5% -$8.64K 0.01% 939
2025
Q4
$1.5M Buy
5,807
+1,097
+23% +$250K 0.01% 1000
2025
Q3
$1.07M Sell
4,710
-64
-1% -$13.1K 0.01% 1057
2025
Q2
$998K Sell
4,774
-160
-3% -$30.8K 0.01% 977
2025
Q1
$962K Buy
4,934
+144
+3% +$29.7K 0.01% 852
2024
Q4
$1.07M Buy
+4,790
New +$1.07M 0.01% 739

Other funds holding MSGS

&Partners's MSGS Position: Q2 2026 in Review

&Partners reduced its Madison Square Garden (MSGS) stake by 1.4% in Q2 2026, selling an estimated $29.4K and leaving 5,695 shares worth $2.28M. The position accounts for 0.01% of the portfolio, ranked #951.

&Partners first reported a position in MSGS in Q4 2024 and has held it in 7 quarters since. 469 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • &Partners held 5,695 shares of Madison Square Garden worth $2.28M as of Q2 2026.
  • &Partners sold 83 Madison Square Garden shares in Q2 2026, an estimated $29.4K.
  • Madison Square Garden made up 0.01% of &Partners's portfolio in Q2 2026, its #951 holding.
  • &Partners first reported a position in Madison Square Garden in Q4 2024 and has held it in 7 quarters since.
  • 469 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.